Research and Reports on Genetics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Rapid Communication - Research and Reports on Genetics (2024) Volume 6, Issue 5

The Role of Epigenetics in Disease: Understanding Heritable Changes Beyond DNA Sequence

M. Tambuwala*

Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India

*Corresponding Author:
M. Tambuwala
Department of Pharmacy, Faculty of Pharmacy
Integral University, Lucknow, India
E-mail: tmahmood@lincoln.ac.uk

Received: 02-Sep-2024, Manuscript No. AARRGS-24- 148036; Editor assigned: 05-Sep-2024, Pre QC No. AARRGS-24- 148036(PQ); Reviewed: 19-Sep-2024, QC No. AARRGS-24-148036; Revised: 23-Sep-2024, Manuscript No. AARRGS-24- 148036 (R); Published: 30-Sep-2024, DOI:10.35841/aarrgs-6.5.222

Citation: Tambuwala M. The role of epigenetics in disease: Understanding heritable changes beyond dna sequence.J Res Rep Genet.2024;6(5):222

Visit for more related articles at Research and Reports on Genetics

Introduction

Epigenetics, the study of changes in gene expression that do not involve alterations to the underlying DNA sequence, has emerged as a crucial field in understanding the complexity of genetic regulation. Unlike genetic mutations, which involve changes in the DNA sequence itself, epigenetic modifications can influence gene activity and contribute to disease development without altering the genetic code. These heritable changes can be influenced by various factors including environmental exposures, lifestyle, and developmental processes. This article delves into the role of epigenetics in disease, exploring how epigenetic modifications contribute to health and disease and the potential for epigenetic therapies in the future [1,2].

The Role of Epigenetics in Disease

Epigenetic modifications include DNA methylation, histone modification, and non-coding RNA interactions. DNA methylation typically represses gene expression by adding methyl groups to cytosine residues, while histone modifications can alter chromatin structure to either enhance or inhibit gene expression. Non-coding RNAs, such as microRNAs, play a role in regulating gene expression posttranscriptionally. These mechanisms can influence cellular processes and contribute to disease when dysregulated [3, 4].

Epigenetics and Complex Diseases

Research has shown that epigenetic changes are involved in the development of various complex diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders. For instance, aberrant DNA methylation patterns can lead to the activation of oncogenes or silencing of tumor suppressor genes in cancer. Similarly, histone modifications have been implicated in the progression of diseases like Alzheimer’s and Parkinson’s [5,6].

Heritable Epigenetic Changes

Unlike genetic mutations, some epigenetic modifications can be passed from one generation to the next. These heritable epigenetic changes can affect offspring's susceptibility to diseases and influence their development. Studies have demonstrated that environmental factors, such as diet and stress, can induce epigenetic changes that are inherited, providing a link between environmental exposures and disease risk across generations [7, 8].

Epigenetic Therapies

The growing understanding of epigenetics has led to the development of novel therapeutic approaches aimed at reversing abnormal epigenetic modifications. Epigenetic drugs, such as DNA methyltransferase inhibitors and histone deacetylase inhibitors, are being explored in clinical trials for various diseases, including cancer and genetic disorders. These therapies offer the potential to correct epigenetic dysregulation and restore normal gene function [9, 10].

Conclusion

Epigenetics has transformed our understanding of gene regulation and disease, highlighting the importance of heritable changes beyond the DNA sequence. By uncovering the role of epigenetic modifications in disease development and progression, researchers are gaining insights into how environmental factors and lifestyle choices can influence genetic expression and contribute to health outcomes. The potential for epigenetic therapies offers hope for new treatments that target the underlying epigenetic mechanisms of disease. As research in epigenetics continues to advance, it will be crucial to further explore these modifications and their implications for personalized medicine, ultimately enhancing our ability to prevent and treat a wide range of diseases.

References

  1. Srivastava D, DeWitt N. In vivo cellular reprogramming: the next generation. Cell 166, 1386–1396 (2016).

    2. Indexed at, Google Scholar, Cross Ref

  2. Schuettengruber B, Bourbon HM, Di Croce L, et al. Genome regulation by polycomb and trithorax: 70 years and counting. Cell 171, 34–57 (2017).

    3. Indexed at, Google Scholar, Cross Ref

  3. Nanney DL. Epigenetic control systems. Proc. Natl Acad. Sci. USA 44, 712–717 (1958).

    4. Indexed at, Google Scholar, Cross Ref

  4. Berger SL, Kouzarides T, Shiekhattar R, et al. An operational definition of epigenetics. Genes Dev. 23, 781–783 (2009).

    5. Indexed at, Google Scholar, Cross Ref

  5. Chen Q, Yan W, Duan E. Epigenetic inheritance of acquired traits through sperm RNAs and sperm RNA modifications. Nat. Rev. Genet. 17, 733–743 (2016).

    6. Indexed at, Google Scholar, Cross Ref

  6. Bonev B, Cavalli G. Organization and function of the 3D genome. Nat. Rev. Genet. 17, 661–678 (2016).

    7. Indexed at, Google Scholar, Cross Ref

  7. Wan G, Fields BD, Spracklin G, et al. Spatiotemporal regulation of liquid-like condensates in epigenetic inheritance. Nature 557, 679–683 (2018).

    8.  Indexed at, Google Scholar, Cross Ref

  8. Irie N, Sybirna A, Surani MA. What can stem cell models tell us about human germ cell biology?. Curr. Top. Dev. Biol. 129, 25–65 (2018).

    9. Indexed at, Google Scholar, Cross Ref

  9. Jullien J, Vodnala M, Pasque V, et al. Gene resistance to transcriptional reprogramming following nuclear transfer is directly mediated by multiple chromatin-repressive pathways. Mol. Cell 65, 873–884.e878 (2017).

    10.  Indexed at, Google Scholar, Cross Ref

  10. Hörmanseder E, Simeone A, Allen GE, et al. H3K4 methylation-dependent memory of somatic cell identity inhibits reprogramming and development of nuclear transfer embryos. Cell Stem Cell 21, 135–143.e136 (2017).

    11. Indexed at, Google Scholar, Cross Ref

Get the App